Literature DB >> 20694659

Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-Jun.

Jukka Westermarck1.   

Abstract

Regulation of protein degradation is an important mechanism by which concentrations of proteins is controlled in cells. In addition to proteins involved in cell cycle regulation or mitosis, protein levels of many transcription factors are regulated by targeted proteosomal degradation. Regulation of protein degradation and stability is usually linked to post-translational modification of the target protein by phosphorylation. The resulting phosphoaminoacid in the context of the adjacent protein sequence is then recognized by E3 ubiquitin ligase enzymes that covalently attach small ubiquitin protein to the target protein and thereby direct them to be degraded by the proteosomes. Here, we present an overview of mechanisms regulating stability of p53, c-Myc, and c-Jun transcription factors. Especially, the purpose is to highlight the role of protein phosphorylation in the regulation of stability of these transcription factors. We also present examples where phosphorylation can either enhance or inhibit protein degradation. Lastly, we discuss the common theme among p53, c-Myc, and c-Jun proteins that the N-terminal phosphorylation both increases the transactivation capacity of the protein and protects the protein from proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694659     DOI: 10.1007/978-1-60761-738-9_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.

Authors:  Maria Lauda Tomasi; Ivan Tomasi; Komal Ramani; Rosa Maria Pascale; Jun Xu; Pasquale Giordano; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

2.  Relevance Rank Platform (RRP) for Functional Filtering of High Content Protein-Protein Interaction Data.

Authors:  Yuba Raj Pokharel; Jani Saarela; Agnieszka Szwajda; Christian Rupp; Anne Rokka; Shibendra Lal Kumar Karna; Kaisa Teittinen; Garry Corthals; Olli Kallioniemi; Krister Wennerberg; Tero Aittokallio; Jukka Westermarck
Journal:  Mol Cell Proteomics       Date:  2015-10-23       Impact factor: 5.911

3.  COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.

Authors:  Jing Shao; Yong Teng; Ravi Padia; Sungguan Hong; Hyangsoon Noh; Xiayang Xie; Jeff S Mumm; Zheng Dong; Han-Fei Ding; John Cowell; Jaejik Kim; Jiahuai Han; Shuang Huang
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

4.  Good COP1 or bad COP1? In vivo veritas.

Authors:  Wenyi Wei; William G Kaelin
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

5.  Redundancy and variation in the ubiquitin-mediated proteolytic targeting of a transcription factor.

Authors:  Eric M Rubenstein; Mark Hochstrasser
Journal:  Cell Cycle       Date:  2010-11-22       Impact factor: 4.534

Review 6.  Molecular Pathways: The Necrosome-A Target for Cancer Therapy.

Authors:  Lena Seifert; George Miller
Journal:  Clin Cancer Res       Date:  2016-12-08       Impact factor: 12.531

7.  Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes.

Authors:  Olga A Issaenko; Alexander Yu Amerik
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

8.  Ubiquitin-Specific Protease USP6 Regulates the Stability of the c-Jun Protein.

Authors:  Lisheng Li; Hong Yang; Yan He; Ting Li; Jinan Feng; Wanze Chen; Lu Ao; Xuying Shi; Yingying Lin; Haoyun Liu; Enrun Zheng; Qiaofa Lin; Jingjing Bu; Yanhua Zeng; Min Zheng; Yan Xu; Zhijun Liao; Jiacheng Lin; Dexin Lin
Journal:  Mol Cell Biol       Date:  2017-12-29       Impact factor: 4.272

9.  Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.

Authors:  Liping Dai; Pengfei Ren; Mei Liu; Haruhiko Imai; Eng M Tan; Jian-Ying Zhang
Journal:  Clin Immunol       Date:  2014-03-22       Impact factor: 3.969

10.  Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model.

Authors:  Luciana A Menescal; Cornelia Schmidt; Daniel Liedtke; Manfred Schartl
Journal:  Dis Model Mech       Date:  2012-03-15       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.